Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:581256.
doi: 10.1155/2014/581256. Epub 2014 Jan 16.

Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration

Affiliations
Review

Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration

Scott Ayton et al. Biomed Res Int. 2014.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor deficits accompanying degeneration of substantia nigra pars compactor (SNc) neurons. Although familial forms of the disease exist, the cause of sporadic PD is unknown. Symptomatic treatments are available for PD, but there are no disease modifying therapies. While the neurodegenerative processes in PD may be multifactorial, this paper will review the evidence that prooxidant iron elevation in the SNc is an invariable feature of sporadic and familial PD forms, participates in the disease mechanism, and presents as a tractable target for a disease modifying therapy.

PubMed Disclaimer

References

    1. Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission. 2003;110(5):517–536. - PubMed
    1. Götz ME, Double K, Gerlach M, Youdim MBH, Riederer P. The relevance of iron in the pathogenesis of Parkinson’s disease. Annals of the New York Academy of Sciences. 2004;1012:193–208. - PubMed
    1. Zecca L, Gallorini M, Schünemann V, et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. Journal of Neurochemistry. 2001;76(6):1766–1773. - PubMed
    1. Lhermitte J, Kraus WM, McAlpine D. On the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation. Journal of Neurology, Neurosurgery & Psychiatry. 1924;195:s1–s5. - PMC - PubMed
    1. Berg D, Grote C, Rausch W-D, et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound in Medicine and Biology. 1999;25(6):901–904. - PubMed

Publication types